Where does SBI Pharmaceuticals Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), SBI Pharmaceuticals Co., Ltd. ranks #8,473 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does SBI Pharmaceuticals Co., Ltd. hold?

SBI Pharmaceuticals Co., Ltd. holds 38 US utility patents granted between 2015 and 2023, spanning 18 technology areas.

What is SBI Pharmaceuticals Co., Ltd.'s Innovation Score?

SBI Pharmaceuticals Co., Ltd. has an Innovation Score of 42.6 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does SBI Pharmaceuticals Co., Ltd. focus on?

SBI Pharmaceuticals Co., Ltd.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 34 patents, ranking #650 of 7,163 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

Is SBI Pharmaceuticals Co., Ltd.'s patent grant rate increasing or decreasing?

SBI Pharmaceuticals Co., Ltd.'s recent grant velocity is -77% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for SBI Pharmaceuticals Co., Ltd.'s patents?

SBI Pharmaceuticals Co., Ltd.'s patents average 10.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the SBI Pharmaceuticals Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

SBI Pharmaceuticals Co., Ltd.

USPTO PatentsView assignee record - 38 granted patents across 18 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, SBI ranks #8,473 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 18 technology areas.

#8,473
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.6/100): 10.1
avg claims per patent: -77%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8473 · Foreign Corporation #8,473 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,473/49,997
PHOTO-FINISH RDI
CPC-FOCUS A61K · 18 areas
INNOV-PAR 42.6/100
CLAIMS-PAR 10.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -77% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: RDI Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How SBI’s 42.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (30%) Velocity 8.9 pts (21%) Breadth 15.0 pts (35%) Claim depth 6.0 pts (14%)

Qualcomm Incorporated · highest

85
Pioneer Surgical… · near

43
Regenesis Bioremedia… · near

43
SBI Pharmaceuticals · this assignee

43
Interactions · near

43
Shinwa Controls · near

43
3D Lighting… · lowest

7

What this shows SBI's Innovation Score is 42.6/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for SBI?

Each dot is one of SBI’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). SBI’s own 10.1 claims/patent is at or below the 14.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

SBI vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where SBI's grants concentrate

SBI Pharmaceuticals Co., Ltd. is a focused PatentsView assignee: 18 CPC subclasses with 89.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (13 grants) versus a trough of 1 in 2020. By volume, SBI sits between RDI Technologies, Inc. and Suzhou Institute OF Nano-tech AND Nano-bionics (SINANO) , Chinese Academy OF Sciences.

SBI's three-year grant acceleration

SBI Pharmaceuticals Co., Ltd. shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

RDI

38
Rohto Pharmaceuti…

38
Red Bull

38
S D Sight Diagnos…

38
Sdcmaterials

38
SDL

38
Shenzhen Hithium…

38
Suzhou Institute…

38
SBI Pharmaceutica… ◀

38

What this shows SBI holds 38 patents at rank #8,472, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near SBI

By rank, the assignees closest to #8,472 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in SBI's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for SBI, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), SBI ranks #650 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Pioneer Surgical Technology, Inc. 43 Regenesis Bioremediation Products 43 Interactions LLC 43 Shinwa Controls Co., Ltd. 43

SBI's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

SBI Pharmaceuticals Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	13.2%
2016	13	34.2%
2017	8	21.1%
2018	5	13.2%
2020	1	2.6%
2021	2	5.3%
2022	2	5.3%
2023	2	5.3%

Which technologies does SBI Pharmaceuticals Co., Ltd. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 34

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 31

C07C - Acyclic OR Carbocyclic Compounds 8

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

Y02A - Technologies FOR Adaptation TO Climate Change 3

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 3

A61B - DIAGNOSIS; SURGERY; Identification 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

C07K - Peptides 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

H04N - Pictorial Communication, e.g. Television 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

SBI Pharmaceuticals Co., Ltd.'s patent record in context - here's where to go next.

SBI Pharmaceuticals Co., Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 89.5% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #8,473 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare SBI Pharmaceuticals Co., Ltd. against RDI Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.